APOD and metabolic syndrome: In agreement with the low levels of HDL-C, MetS patients had significantly lower levels of ApoA-I and ApoD (Figure 2a,b), while ApoA-IV, ApoM, ApoE, ApoC-I, and ApoB-100 did not show significant differences between groups (Figure 2c–g).